Mirum Pharmaceuticals (MIRM) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-1.94
-1.56
-1.18
-0.8

Details

Expected EPS
-0.81
Actual EPS
-1.94
Surprise EPS
-1.13
Surprise Percent
+139.51%

Description

Mirum Pharmaceuticals (MIRM) has reported earnings of -1.94 per share for Q2 2023.

0 Comments

Share your thoughts